Granulocyte colony stimulating factor in neonatal alloimmune neutropenia: A possible association with induced thrombocytopenia |
| |
Authors: | Christina Wiedl DO Andrew W. Walter MS MD |
| |
Affiliation: | 1. Department of Pediatric Hematology/Oncology, University of Rochester School of Medicine and Dentistry, Rochester, New York;2. Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania;3. Associate Professor of Pediatrics;4. Attending physician, A. I. duPont Hospital for Children, Wilmington, DE. |
| |
Abstract: | ![]() Neonatal alloimmune neutropenia (NAIN) is a rare cause of congenital neutropenia seen in <1% of births. Significant morbidity, usually infections, may result from this disease. The pathophysiology of NAIN, mediated by maternal antibodies crossing the placenta to destroy fetal cells expressing paternal antigens, is similar to that of neonatal alloimmune thrombocytopenia, as well as Rh/ABO hemolytic disease of the newborn. The use of high‐dose granulocyte colony stimulating factor in patients with NAIN may cause a reversible thrombocytopenia in some patients. Pediatr Blood Cancer 2010;54:1014–1016 © 2010 Wiley‐Liss, Inc. |
| |
Keywords: | cytokines immune cytopenias neonatology neutropenia thrombocytopenia |
|
|